LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models ; volume:18 ; number:1 ; day:9 ; month:5 ; year:2018 ; pages:1-9 ; date:12.2018
Cancer cell international ; 18, Heft 1 (9.5.2018), 1-9, 12.2018
- Creator
-
Regufe da Mota, Sergio
- Contributor
-
Bailey, Sarah
Strivens, Rosemary A.
Hayden, Annette L.
Douglas, Leon R.
Duriez, Patrick J.
Borrello, M. Teresa
Benelkebir, Hanae
Ganesan, A.
Packham, Graham
Crabb, Simon J.
SpringerLink (Online service)
- DOI
-
10.1186/s12935-018-0568-1
- URN
-
urn:nbn:de:101:1-2018071419245140814197
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Regufe da Mota, Sergio
- Bailey, Sarah
- Strivens, Rosemary A.
- Hayden, Annette L.
- Douglas, Leon R.
- Duriez, Patrick J.
- Borrello, M. Teresa
- Benelkebir, Hanae
- Ganesan, A.
- Packham, Graham
- Crabb, Simon J.
- SpringerLink (Online service)
Other Objects (12)
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
Evaluation of androgen receptor and androgen receptor splice-variant 7 in bladder cancer; a novel approach into an ancient topic
Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer
Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer
Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy
Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor
Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade
Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
Evaluation of androgen receptor and androgen receptor splice-variant 7 in bladder cancer; a novel approach into an ancient topic
Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer
Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer
Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy
Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor
Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade
Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
Evaluation of androgen receptor and androgen receptor splice-variant 7 in bladder cancer; a novel approach into an ancient topic
Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer
Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer
Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy
Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor
Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade
Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy